awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50119590-3F2284A6-5FF9-4786-B26F-6B2355E8C592
Q50119590-3F2284A6-5FF9-4786-B26F-6B2355E8C592
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50119590-3F2284A6-5FF9-4786-B26F-6B2355E8C592
Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.
P2860
Q50119590-3F2284A6-5FF9-4786-B26F-6B2355E8C592
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50119590-3F2284A6-5FF9-4786-B26F-6B2355E8C592
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d8f8ba29ff3dd0c4ed47173e527bd3e87d3fc67
P2860
Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure.